Advanced Therapy Medicinal Products (ATMP) and Regulatory Clarity
The European regulatory landscape for nucleic acid therapeutics is governed by the Advanced Therapy Medicinal Products (ATMP) framework. This specialized legislation provides a clear pathway for the approval of gene therapies, somatic cell therapies, and tissue-engineered products. By centralizing the approval process through the EMA’s Committee for Advanced Therapies (CAT), Europe offers...
0 Commenti 0 condivisioni 400 Views 0 Anteprima
Sponsorizzato